Creative Planning - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 216 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2023. The put-call ratio across all filers is 2.45 and the average weighting 0.2%.

Quarter-by-quarter ownership
Creative Planning ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q3 2023$5,022
+0.4%
1000.0%0.00%
Q2 2017$5,000
-79.2%
100
-83.3%
0.00%
Q1 2017$24,000
+700.0%
600
+500.0%
0.00%
Q4 2016$3,0000.0%1000.0%0.00%
Q3 2016$3,000
+50.0%
1000.0%0.00%
Q2 2016$2,0000.0%1000.0%0.00%
Q1 2016$2,000
-33.3%
1000.0%0.00%
Q4 2015$3,000
+50.0%
1000.0%0.00%
Q3 2015$2,0001000.00%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q3 2023
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 716,539$36,192,00012.35%
CADIAN CAPITAL MANAGEMENT, LP 2,020,629$102,062,0006.89%
Casdin Capital, LLC 1,150,000$58,087,0004.91%
DAFNA Capital Management LLC 261,280$13,197,0003.60%
Nextech Invest Ltd. 188,228$9,507,0003.21%
Eagle Health Investments LP 170,551$8,615,0002.01%
Boxer Capital, LLC 507,374$25,627,0001.62%
Rock Springs Capital Management LP 979,174$49,458,0001.44%
EFG Asset Management (North America) Corp. 130,454$6,589,0001.39%
Integral Health Asset Management, LLC 130,000$6,566,0001.35%
View complete list of BLUEPRINT MEDICINES CORP shareholders